Ureaplasma urealyticum arthritis and bacteremia in agammaglobulinemia

Pediatric Infectious Disease Journal

Volumn 17, Issue 1, 1998, Pages 73-76

  Asmar, Basim I ^a,b   Andresen, Jennie ^a,b,c   Brown, William J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Agammaglobulinemia; Arthritis; Bacteremia; Mycoplasma; Ureaplasma urealyticum

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; IMMUNOGLOBULIN; OFLOXACIN; STREPTOMYCIN; TETRACYCLINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ARTHRITIS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HUMAN; INFECTION SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UREAPLASMA UREALYTICUM; X LINKED AGAMMAGLOBULINEMIA;

ADOLESCENT; AGAMMAGLOBULINEMIA; ARTHRITIS, INFECTIOUS; BACTEREMIA; HUMANS; MALE; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 0031910323     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199801000-00017     Document Type: Article

References (21)

1. Shepard MC, Combs RS. Enhancement of Ureaplasma urealyticum growth on a differential agar medium (A7B) by a polyamine, putrescine. J Clin Microbiol 1979;10:931-33.
2. Waites KB, Crouse DT, Cassell GH. Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates. Pediatr Infect Dis J 1992;11:23-9.
3. Furr PM, Taylor-Robinson D, Webster ADB. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years. Ann Rheum Dis 1994;53:183-7.
4. Roifman CM, Rao CP, Lederman HM, Lavi S, Quinn P, Gelfand EW. Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia. Am J Med 1986;80:590-4.
5. Powell DA, Clyde WA. Opsonin-reversible resistance of Mycoplasma pneumoniae to in vitro phagocytosis by alveolar macrophages. Infect Immun 1975;11:540-50.
6. Taylor G, Taylor-Robinson D. Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice. Immunology 1976;30:611-8.
7. Taylor-Robinson D, Furr PM, Fimls, Webster ADB. Ureaplasma urealyticum in the immunocompromised host. Pediatr Infect Dis 1986:5:S236-8.
8. Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 1989;9:22-33.
9. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine 1985;64:145-56.
10. Hermans PE, Diaz-Buxo JA, Stobo JD. Idiopathic late-onset immunoglobulin deficiency: clinical observations in 50 patients. Am J Med 1976;61:221-37.
11. Hansel TT, Haeney MR, Thompson RA. Primary hypogammaglobulinaemia and arthritis. Br Med J Clin Res Ed 1987: 295:174-5.
12. Webster AD, Loewi G, Dourmashkin RD, Golding DV, Ward DJ, Asherson GI. Polyarthritis in adults with hypogammaglobulinaemia and its rapid response to immunoglobulin treatment. Br Med J 1976;1:1314-16.
13. Webster AD, Taylor-Robinson D, Furr PM, Asherson GL. Mycoplasmal (Ureaplasma) septic arthritis in hypogammaglobulinaemia. Br Med J 1978;1:478-9.
14. Stuckey M, Quinn PA, Gelfand EW. Identification of Ureaplasma urealyticum (T-strain Mycoplasma) in patients with polyarthritis. Lancet 1978;2:917-20.
15. Vogler LB, Waites KB, Wright PF, Perrin JM, Cassell GH. Ureaplasma urealyticum polyarthritis in agammaglobulinemia. Pediatr Infect Dis 1985;4:687-91.
16. Forgacs P, Kundsin RB, Margles SW, Silverman ML, Perkins RE. A case of Ureaplasma urealyticum septic arthritis in a patient with hypogammaglobulinemia. Clin Infect Dis 1993; 16:293-4.
17. Kraus NB, Baraniuk JM, Hill GB, Allen Bates N. Ureaplasma urealyticum septic arthritis in hypogammaglobulinemia. J Rheumatol 1988;15:369-71.
18. Walker RC, Wright AJ. The fluoroquinolones. Mayo Clin Proc 1991;66:1249-59.
19. Waites KB, Cassell GH. Clinical applications of fluoroquinolones for genital Mycoplasma infections. Infect Med 1994;11: 71-80, 88.
20. Kaku M, Ishida K, Irifune K, et al. In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae. Antimicrob Agents Chemother 1994:38:738-41.
21. Perea EJ, Aznar J, Garcia-Iglesias MC, Pascual A. Comparative in-vitro activity of sparfloxacin against genital pathogens. J Antimicrob Chemother 1996;37(Suppl A):19-25.